The airway management devices market is expected to be worth USD 1.6 billion in 2023 and expected to record a 3.6% CAGR from 2023 to 2033, reaching around USD 2.2 billion.
| Report Attribute | Details |
|---|---|
| Airway Management Devices Market Value (2023) | USD 1.6 billion |
| Airway Management Devices Market Anticipated Value (2033) | USD 2.2 billion |
| Airway Management Devices Market Growth Rate (2023 to 2033) | 3.6% CAGR |
Airway management devices are used to keep or restore a patient's ventilation. These devices also include assessing, planning, and implementing various medical methods to treat patients with respiratory failures or acute blockages. Aside from that, it shields the lungs from harm and allows patients to exchange gas. Supraglottic airway devices (SADs), tracheal intubation, trans tracheal access, and airway clearance are a few of the most often utilised airway management devices for keeping the upper airway open and providing unobstructed ventilation
Patients may require airway care for a variety of reasons, ranging from simple choking to complicated airway obstruction. For airway management, several specific clinical signs must be evaluated. Among them are respiratory failure, poor consciousness, rapid changes in mental status, aggressive choking, and penetrating injuries.
Depending on the circumstances, hospitals may employ a variety of airway management procedures. Basic airway care employs non-invasive techniques that do not need the use of specialist medical devices. Techniques to remove foreign bodies from the airway include chest compressions, abdominal thrusts, and back strikes. These factors are expected to drive the growth of the airway management devices market in the approaching years.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Patients with viral, chronic, or cardiac illnesses frequently experience airway issues, necessitating rapid medical attention. The demand for airway management devices is increasing as a result of a variety of circumstances, including traffic accident victims and people suffering from other traumatic injuries.
The global demand for airway management devices is increasing due to critically ill and trauma patients being admitted to emergency rooms and intensive care units. As a result of the pandemic's rapid spread, admissions to emergency rooms and intensive care units have skyrocketed worldwide. These factors are expected to drive future growth in the airway management devices market.
The Airway management devices market was valued at USD 1.5 billion in 2022 and is estimated to increase at a 3.2% CAGR during the forecast period. Absolute dollar growth in the global market is USD 668.5 million.
The increase in funds allocated by the federal government to promote the use of airway-management medical devices has also had an impact on the expansion of the airway-management devices market share. The revenue generated by the airway management devices market is additionally boosted by growing healthcare spending, improvements in healthcare infrastructure, and an increase in the need for long-term care delivery.
Furthermore, the respiratory system alters geometrically, physiologically, and immunologically as we age. Chest wall and thoracic spine deformities are examples of structural anomalies that influence overall respiratory system compliance, resulting in airway irritation.
The increased incidence of respiratory infections and anaesthesia consumption as a result of more surgeries are expected to fuel the demand for airway management devices and positively impact the global airway management devices market growth. Moreover, as a result of technical advancements, key competitors are forging strategic alliances to boost the airway management device market. This feature is projected to generate several chances for key players to boost the airway management devices market.
Principal Consultant
Advancement in airway management technology for the management of paediatric airways is expected to boost the airway management device market growth over the forecast period. Children have different anatomy and physiology structures as compared to adults. Also, the diagnosis and treatment of paediatric airways is difficult. Technological advancements can provide ease in paediatric airway diagnosis and treatment.
Airway management is the priority in any critical patient. Hypoxia can cause irreversible brain injury. So, in this type of state, airway management is the first priority before proceeding to any other treatment. This creates opportunities in the market for new device innovation and market growth.
Currently, manufacturers of airway management devices are consistently making changes in their product categories and technologies in order to enhance the capabilities of the devices. This is expected to enhance their sale and increase the market share in the long term.
The global airway management devices market is expected to record a CAGR of 3.2% through the forecast period from 2022 to 2028.
Which Factors are Restraining the Demand for Airway Management Devices Market?
Complications and limitations associated with airway management due to intubation and other factors are expected to hamper the global airway management devices market growth.
Endotracheal intubation is a commonly performed airway management procedure in hospitals, but it also comprises risks and complications. Endotracheal intubation involves the risk of injuries such as dental injury, nasoseptal injury, laryngotracheal stenosis, and tracheoesophageal fistulas, among others.
Dental trauma is also associated with laryngeal mask airway and oropharyngeal airway devices. Moreover, limitations & contraindications associated with laryngeal mask airway devices include morbid obesity, non-fasted patients, and airway problems at the glottic level, thoracic trauma, and the necessity for high inspiratory pressure in the presence of pulmonary compliance and COPD.
Product recalls of airways management devices are negatively affecting the growth of the global airways management device market. Due to the product recalls, the company losses their brand image and thus, these recalls negatively impact the revenue of the company.
The rise in Respiratory Disease Prevalence to Drive Airway Management Devices Market Growth
The rise in chronic respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD) is fueling demand for airway management devices. Chronic obstructive pulmonary disorders, such as bronchitis and emphysema, as well as lung cancer and other respiratory tract neoplasms, have a substantial impact on airways and lung structures. The prevalence of respiratory disorders is rising as a result of environmental and lifestyle factors such as air pollution, smoking, sedentary lifestyles, and stress.
Demand for airway management devices is being driven by increased patients suffering from such diseases, and the quick introduction and availability of portable, cost-contained, and simple-to-use airway equipment for the treatment of such ailments. Airway stenting and airway clearing systems are the two distinct therapies that make use of airway management devices.
According to the World Health Organization (WHO), over 65 million individuals had chronic obstructive pulmonary disease (COPD), and 3 million died from it, making it the third-leading cause of mortality in the world. More than 80% of these fatalities occurred in poor and middle-income nations.
Asthma affects about 262 million individuals worldwide each year, making it the most common chronic paediatric condition, affecting 14% of all children. Tuberculosis (TB) killed around 1.4 million people in 2022, making it the most prevalent deadly infectious illness. Lung cancer is the deadliest type of cancer, killing 1.6 million people each year.
The chronic respiratory disease kills 4 million individuals prematurely worldwide. At least 2 billion individuals are exposed to harmful smoke indoors, 1 billion to outdoor pollutants in the air, and 1 billion to cigarette smoke.
The Elderly Population's High Susceptibility to Chronic Respiratory Diseases will drive demand for Airway Management Devices
The rise in world population can be ascribed to an increase in people's life expectancy over the last decade. A person's immune system diminishes with age. Consequently, the growing older population increases the risk of developing numerous diseases. The amount of adults above the age of 60 is likely to increase in the future years. Additionally, chronic respiratory illnesses have become common as the elderly population has grown. This is expected to drive demand for airway management devices over the projected period.
An increase in the prevalence of chronic respiratory diseases (CRD) in adults is estimated to boost the demand for airway management devices. According to Centres for Disease Control and Prevention (CDC) data, the prevalence of COPD, emphysema, or chronic bronchitis in adults increased in 2023. As a result, individuals suffering from emphysema or chronic bronchitis have raised global demand for airway management equipment.
Increased demand for Single-use Airway Management Devices is likely to create numerous opportunities.
Airway management devices are among the medical devices utilized in a variety of applications within the healthcare business. Single-use medical equipment are resuscitators, tracheostomy tubes, laryngoscope blades, and resuscitators endotracheal tubes. These are widely used in healthcare facilities to provide value-based care services and treat critically ill patients with highly contagious illnesses such as H1N1 influenza or severe pneumonia.
Furthermore, single-use devices have several advantages over reusable ones because they are already cleaned and ready to use, safeguarding patients from medical-care-related infections. In the past, it extended the use of single-use airway management devices throughout healthcare facilities to meet infection-control regulations.
One of the primary factors driving the market is the rising frequency of respiratory disorders. Furthermore, the use of anaesthesia is increasing due to rising procedures. This, together with the numerous advantages of airway management systems, such as high efficiency in airway clearance, the maintenance of proper ventilation and patient safety during operating procedures, are also contributing to market expansion.
Furthermore, a surge in the emergency treatment of extended illness and protracted treatment associated with lung illnesses in children and adults is fuelling demand for airway management devices. Furthermore, the introduction of new procedures for preoperative airway examination is bolstering market growth.
For example, Preoperative Endoscopic Airway Evaluation (PEAE) is a procedure that identifies, predicts, and facilitates an efficient management strategy, which includes the use of sophisticated equipment such as supraglottic airway. These airway devices facilitate tracheal implantation, which improves patient safety, and are then used in a variety of therapeutic applications.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Country | United States |
|---|---|
| CAGR (2017 to 2022) | 3.2% |
| Valuation (2023 to 2033) | USD 66.5 million |
| Country | China |
|---|---|
| CAGR (2017 to 2022) | 5.0% |
| Valuation (2023 to 2033) | USD 107.0 million |
| Country | Japan |
|---|---|
| CAGR (2017 to 2022) | 3.4% |
| Valuation (2023 to 2033) | USD 135.5 million |
| Country | India |
|---|---|
| CAGR (2017 to 2022) | 3.7% |
| Valuation (2023 to 2033) | USD 46.2 million |
Because of the prevalence of asthma and chronic obstructive pulmonary disease, as well as the expanding older population, North America dominates the market for airway management devices. According to the United States Census Bureau, more than 50 million Americans aged 65 and older are at high risk of acquiring chronic diseases that necessitate immediate ventilation as of 2022.
The United States and Canada are two significant countries in North America where such medical gadgets have been widely embraced. The primary causes of the growth in the demand for airway management devices in North America include rising pollution levels and an increase in respiratory disorders, even in newborn care.
Due to advantageous reimbursement policies, an increase in healthcare R&D spending, and a growth in the incidence of chronic diseases such as COPD, the United States market is expected to expand significantly throughout the forecast period. COPD affects 12.7 to 14.7 million persons in the United States, according to the WHO data. The presence of the medical industry in North America will aid in the expansion of the region's airway management device market share.
The United States is estimated to account for 92.7% of the North American airway management devices market in 2022 owing to the high acceptance of technologically advanced products, increase in the prevalence of chronic respiratory diseases, and favourable reimbursement regulations for airway management devices in the region.
Germany accounted for 18.3% market share in Europe in 2022 in value terms. Industrial advancement, the geriatric population and the rise in research and development spending are the factor boosting the demand for airway management devices market in Germany.
The risk associated with airways related problems increases with age. The growing geriatric population is considered an important factor bolstering the airway management devices market. According to the available WHO data from 2018, lung disease fatalities in Germany were 48,209, accounting for 6.27% of all deaths. Germany ranks 112 in the world with an age-adjusted death rate of 20.04 per 100,000 of population.
Recently demand for airway management devices market in China owing to an increase in the outsourcing of the manufacturing airway management devices led to account over 20% market share in 2022 in the Asia Pacific region.
Government and administrative assortments in China are adopting different cost-control measures to decrease the healthcare burden. This move from a volume- to a value-based framework is fuelled by different measures taken by healthcare providers, medical device companies, governments and insurance payers that incorporate result-based estimating, price control and competitive tendering, profit, and risk sharing.
Furthermore, the presence of untapped opportunities in this region, as well as the rising burden of the ageing populations, who are more susceptible to chronic respiratory disorders, rapid industrialization, and an increase in disposable income are the significant factors expected to propel the airway management devices market during the forecasted period. Moreover, increasing awareness and disease prevalence along with a strong foothold of leading industry players generated abundant growth potential in this region.
Endobronchial tubes accounted for a significant share of over 43.0% in 2021. The growing demand for these products is due to the benefits they provide. The most important benefit is improved patient safety, which encourages patients and anesthesiologists to choose these devices.
The introduction of a single or double-lumen endobronchial tube with a camera offers a promising solution in thoracoscopic lung surgery, as well as being advantageous in robotic surgery. During installation and single lung ventilation, a single/double-lumen endobronchial tube with a camera offers continuous real-time monitoring. This factor can further propel the airway management devices market.
By usage type, single-use/ disposable accounted for 83.1% of the market share in 2022 due to its safety purpose with infection prevention and reduced chance of cross-infection. Airway management devices are directly used in the human airway lumen for instant relief.
So for such delivery, patient safety and infection prevention are at most priority that is easily achieved by single-use devices. Disposable devices avoid cross-infection risk, are easy to insert and are proven to be a safe method for airway management as compared to tubes. These factors are gaining traction for the market growth at present and in the forecast period.
By end user, hospitals dominated the market with a market share of 47.8% in 2022 owing to increasing surgical procedures including the use of airway management equipment for ventilation, oxygenation, and anaesthetic administration. Additionally, airway management devices are easily handled in hospitals.
Also, the more walk-in patient is seen in hospitals and growing government efforts targeted at enhancing safety and preventing adverse occurrences are significant contributors to the segment's growth in the forecast period.
The global market for airway management devices is highly concentrated, with a limited amount of large-scale vendors controlling the majority of market share. Key participants in the global market include:
| Attribute | Details |
|---|---|
| Market Size Value in 2023 | USD 1.6 billion |
| Market Size Value in End of Forecast (2033) | USD 2.2 billion |
| Market Analysis | USD billion for Value |
| Key Region Covered | North America; Latin America; Europe; Asia Pacific; The Middle East & Africa |
| Key Segments | By Product Type, By Usage Type, By End User, By Region |
| Key Companies Profiled | Medtronic Plc; Teleflex Incorporated; Ambu A/S; Smith’s Group plc.; Intersurgical Ltd.; Cook Medical Inc.; SunMed; Vyaire Medical Inc; VBM Medizintechnik GmbH; Karl Storz SE & Co. KG; Cook Gas LLC; Flexicare (Group) Limited; BVLM Pty Ltd; Boston Medical Products Inc. (BESS GROUP); Salter Labs |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
The market is valued at USD 1.6 billion in 2023.
The market is projected to reach 3.6% CAGR.
The market will grow by USD 2.2 billion in 2033.
China's market is expected to be worth USD 135.5 million by 2033.
Medtronic Plc, Teleflex Incorporated, and Ambu A/S are key players.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Analysis 2017 to 2022 and Forecast, 2023 to 2033 5. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Laryngeal Masks 5.2. Tracheostomy Tubes 5.3. Endotracheal Tubes 5.4. Endobronchial Tubes 5.5. Nasal Airway Tubes 5.6. Oral Airway Tubes 6. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Usage Type 6.1. Single Use/ Disposable 6.2. Reusable 7. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User 7.1. Hospitals 7.2. Ambulatory Surgical Centers 7.3. Specialty Clinics 8. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region 8.1. North America 8.2. Latin America 8.3. Europe 8.4. Asia Pacific 8.5. MEA 9. North America Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 10. Latin America Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 11. Europe Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 12. Asia Pacific Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 13. MEA Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 14. Key Countries Analysis 15. Market Structure Analysis 16. Competition Analysis 16.1. Medtronic Plc 16.2. Teleflex Incorporated 16.3. Ambu A/S 16.4. Smiths Group plc. 16.5. Intersurgical Ltd. 16.6. Cook Medical Inc. 16.7. SunMed 16.8. Vyaire Medical Inc 16.9. VBM Medizintechnik GmbH 16.10. Karl Storz SE & Co. KG 16.11. Cook Gas LLC 16.12. Flexicare (Group) Limited 16.13. BVLM Pty Ltd 16.14. Boston Medical Products Inc. 17. Assumptions & Acronyms Used 18. Research Methodology
Explore Healthcare Insights
View Reports
Airway Management Devices Market
